Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1992 Mar 1;89(5):1572–1576. doi: 10.1073/pnas.89.5.1572

Neuronal-type alpha-bungarotoxin receptors and the alpha 5-nicotinic receptor subunit gene are expressed in neuronal and nonneuronal human cell lines.

B Chini 1, F Clementi 1, N Hukovic 1, E Sher 1
PMCID: PMC48494  PMID: 1542648

Abstract

alpha-Bungarotoxin (alpha Bgtx) is a toxin known to interact with muscle nicotinic receptors and with some neuronal nicotinic receptors. We show that alpha Bgtx binding sites are also expressed in nonmuscle and nonneuronal human cells, including small cell lung carcinoma and several epithelial cell lines. These receptors are immunologically related to the alpha Bgtx receptors of unknown function described in the nervous system and in the IMR32 neuroblastoma cell line and are distinct from muscle nicotinic receptors. We have also cloned from IMR32 cells the human alpha 5-nicotinic receptor subunit, which is supposed to participate in the formation of alpha Bgtx receptors. Transcripts corresponding to the alpha 5-subunit gene were found not only in neuroblastoma cells but also in all the cell lines expressing alpha Bgtx receptors, with the exception of the TE671 cell line, whose nicotinic receptor subunits are of the muscle type. We conclude that both alpha Bgtx receptors and the alpha 5-nicotinic subunit gene are not neuron-specific, as previously thought, but are expressed in a number of human cell lines of various origin.

Full text

PDF
1572

Images in this article

1574Image
on p.1574
1576Image
on p.1576

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anand R., Lindstrom J. Nucleotide sequence of the human nicotinic acetylcholine receptor beta 2 subunit gene. Nucleic Acids Res. 1990 Jul 25;18(14):4272–4272. doi: 10.1093/nar/18.14.4272. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Boulter J., O'Shea-Greenfield A., Duvoisin R. M., Connolly J. G., Wada E., Jensen A., Gardner P. D., Ballivet M., Deneris E. S., McKinnon D. Alpha 3, alpha 5, and beta 4: three members of the rat neuronal nicotinic acetylcholine receptor-related gene family form a gene cluster. J Biol Chem. 1990 Mar 15;265(8):4472–4482. [PubMed] [Google Scholar]
  3. Clementi F., Cabrini D., Gotti C., Sher E. Pharmacological characterization of cholinergic receptors in a human neuroblastoma cell line. J Neurochem. 1986 Jul;47(1):291–297. doi: 10.1111/j.1471-4159.1986.tb02861.x. [DOI] [PubMed] [Google Scholar]
  4. Clementi F., Sher E. Antibody induced internalization of acetylcholine nicotinic receptor: kinetics, mechanism and selectivity. Eur J Cell Biol. 1985 May;37:220–228. [PubMed] [Google Scholar]
  5. Couturier S., Bertrand D., Matter J. M., Hernandez M. C., Bertrand S., Millar N., Valera S., Barkas T., Ballivet M. A neuronal nicotinic acetylcholine receptor subunit (alpha 7) is developmentally regulated and forms a homo-oligomeric channel blocked by alpha-BTX. Neuron. 1990 Dec;5(6):847–856. doi: 10.1016/0896-6273(90)90344-f. [DOI] [PubMed] [Google Scholar]
  6. Couturier S., Erkman L., Valera S., Rungger D., Bertrand S., Boulter J., Ballivet M., Bertrand D. Alpha 5, alpha 3, and non-alpha 3. Three clustered avian genes encoding neuronal nicotinic acetylcholine receptor-related subunits. J Biol Chem. 1990 Oct 15;265(29):17560–17567. [PubMed] [Google Scholar]
  7. Cunningham J. M., Lennon V. A., Lambert E. H., Scheithauer B. Acetylcholine receptors in small cell carcinomas. J Neurochem. 1985 Jul;45(1):159–167. doi: 10.1111/j.1471-4159.1985.tb05488.x. [DOI] [PubMed] [Google Scholar]
  8. Deneris E. S., Connolly J., Rogers S. W., Duvoisin R. Pharmacological and functional diversity of neuronal nicotinic acetylcholine receptors. Trends Pharmacol Sci. 1991 Jan;12(1):34–40. doi: 10.1016/0165-6147(91)90486-c. [DOI] [PubMed] [Google Scholar]
  9. Engel E. K., Trotter J. L., McFarlin D. E., McIntosh C. L. Thymic epithelial cell contains acetylcholine receptor. Lancet. 1977 Jun 18;1(8025):1310–1311. doi: 10.1016/s0140-6736(77)91343-5. [DOI] [PubMed] [Google Scholar]
  10. Fornasari D., Chini B., Tarroni P., Clementi F. Molecular cloning of human neuronal nicotinic receptor alpha 3-subunit. Neurosci Lett. 1990 Apr 6;111(3):351–356. doi: 10.1016/0304-3940(90)90287-j. [DOI] [PubMed] [Google Scholar]
  11. GREENWOOD F. C., HUNTER W. M., GLOVER J. S. THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. Biochem J. 1963 Oct;89:114–123. doi: 10.1042/bj0890114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gotti C., Ogando A. E., Clementi F. The alpha-bungarotoxin receptor purified from a human neuroblastoma cell line: biochemical and immunological characterization. Neuroscience. 1989;32(3):759–767. doi: 10.1016/0306-4522(89)90296-0. [DOI] [PubMed] [Google Scholar]
  13. Gotti C., Ogando A. E., Hanke W., Schlue R., Moretti M., Clementi F. Purification and characterization of an alpha-bungarotoxin receptor that forms a functional nicotinic channel. Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3258–3262. doi: 10.1073/pnas.88.8.3258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gotti C., Wanke E., Sher E., Fornasari D., Cabrini D., Clementi F. Acetylcholine operated ion channel and alpha-bungarotoxin binding site in a human neuroblastoma cell line reside on different molecules. Biochem Biophys Res Commun. 1986 Jun 30;137(3):1141–1147. doi: 10.1016/0006-291x(86)90344-x. [DOI] [PubMed] [Google Scholar]
  15. Kirchner T., Tzartos S., Hoppe F., Schalke B., Wekerle H., Müller-Hermelink H. K. Pathogenesis of myasthenia gravis. Acetylcholine receptor-related antigenic determinants in tumor-free thymuses and thymic epithelial tumors. Am J Pathol. 1988 Feb;130(2):268–280. [PMC free article] [PubMed] [Google Scholar]
  16. Lukas R. J., Audhya T., Goldstein G., Lucero L. Interactions of the thymic polypeptide hormone thymopoietin with neuronal nicotinic alpha-bungarotoxin binding sites and with muscle-type, but not ganglia-type, nicotinic acetylcholine receptor ligand-gated ion channels. Mol Pharmacol. 1990 Dec;38(6):887–894. [PubMed] [Google Scholar]
  17. Luther M. A., Schoepfer R., Whiting P., Casey B., Blatt Y., Montal M. S., Montal M., Linstrom J. A muscle acetylcholine receptor is expressed in the human cerebellar medulloblastoma cell line TE671. J Neurosci. 1989 Mar;9(3):1082–1096. doi: 10.1523/JNEUROSCI.09-03-01082.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Maneckjee R., Minna J. D. Opioid and nicotine receptors affect growth regulation of human lung cancer cell lines. Proc Natl Acad Sci U S A. 1990 May;87(9):3294–3298. doi: 10.1073/pnas.87.9.3294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Matsumoto Y., Furuya A., Kobayashi T., Tsukagoshi H. Primary cultures of human myasthenia gravis thymus and normal thymus. Studies of cell morphology, cell proliferative pattern and localization of alpha-bungarotoxin binding sites on cultured thymic cells. J Neurol Sci. 1986 Sep;75(2):121–133. doi: 10.1016/0022-510x(86)90088-2. [DOI] [PubMed] [Google Scholar]
  20. McLane K. E., Wu X. D., Conti-Tronconi B. M. Identification of a brain acetylcholine receptor alpha subunit able to bind alpha-bungarotoxin. J Biol Chem. 1990 Jun 15;265(17):9816–9824. [PubMed] [Google Scholar]
  21. Patrick J., Stallcup B. alpha-Bungarotoxin binding and cholinergic receptor function on a rat sympathetic nerve line. J Biol Chem. 1977 Dec 10;252(23):8629–8633. [PubMed] [Google Scholar]
  22. Quik M., Babu U., Audhya T., Goldstein G. Evidence for thymopoietin and thymopoietin/alpha-bungarotoxin/nicotinic receptors within the brain. Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2603–2607. doi: 10.1073/pnas.88.6.2603. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  23. Quik M., Geertsen S. Neuronal nicotinic alpha-bungarotoxin sites. Can J Physiol Pharmacol. 1988 Aug;66(8):971–979. doi: 10.1139/y88-160. [DOI] [PubMed] [Google Scholar]
  24. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Schoepfer R., Conroy W. G., Whiting P., Gore M., Lindstrom J. Brain alpha-bungarotoxin binding protein cDNAs and MAbs reveal subtypes of this branch of the ligand-gated ion channel gene superfamily. Neuron. 1990 Jul;5(1):35–48. doi: 10.1016/0896-6273(90)90031-a. [DOI] [PubMed] [Google Scholar]
  26. Siara J., Rüdel R., Marx A. Absence of acetylcholine-induced current in epithelial cells from thymus glands and thymomas of myasthenia gravis patients. Neurology. 1991 Jan;41(1):128–131. doi: 10.1212/wnl.41.1.128. [DOI] [PubMed] [Google Scholar]
  27. Stroud R. M., McCarthy M. P., Shuster M. Nicotinic acetylcholine receptor superfamily of ligand-gated ion channels. Biochemistry. 1990 Dec 18;29(50):11009–11023. doi: 10.1021/bi00502a001. [DOI] [PubMed] [Google Scholar]
  28. Tominaga K., Kinoshita Y., Hato F., Masudå A., Matsuyama M. Effects of cholinergic agonists on the proliferation and protein synthesis in a cultured thymic epithelial cell line. Cell Mol Biol. 1989;35(6):679–686. [PubMed] [Google Scholar]
  29. Tzartos S. J., Rand D. E., Einarson B. L., Lindstrom J. M. Mapping of surface structures of electrophorus acetylcholine receptor using monoclonal antibodies. J Biol Chem. 1981 Aug 25;256(16):8635–8645. [PubMed] [Google Scholar]
  30. Utkin YuN, Lazakovich E. M., Kasheverov I. E., Tsetlin V. I. alpha-Bungarotoxin interacts with the rat brain tachykinin receptors. FEBS Lett. 1989 Sep 11;255(1):111–115. doi: 10.1016/0014-5793(89)81071-3. [DOI] [PubMed] [Google Scholar]
  31. Weynants P., Humblet Y., Canon J. L., Symann M. Biology of small cell lung cancer: an overview. Eur Respir J. 1990 Jun;3(6):699–714. [PubMed] [Google Scholar]
  32. Whiting P. J., Cooper J., Lindstrom J. M. Antibodies in sera from patients with myasthenia gravis do not bind to nicotinic acetylcholine receptors from human brain. J Neuroimmunol. 1987 Oct;16(2):205–213. doi: 10.1016/0165-5728(87)90075-0. [DOI] [PubMed] [Google Scholar]
  33. Whiting P., Lindstrom J. Pharmacological properties of immuno-isolated neuronal nicotinic receptors. J Neurosci. 1986 Oct;6(10):3061–3069. doi: 10.1523/JNEUROSCI.06-10-03061.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. von Heijne G. A new method for predicting signal sequence cleavage sites. Nucleic Acids Res. 1986 Jun 11;14(11):4683–4690. doi: 10.1093/nar/14.11.4683. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES